Stig Hansen PhD

Dr Stig Hansen, Co-founder and Chief Executive Officer, holds an M.S. in biochemistry and a PhD in molecular and cell biology from the University of Copenhagen, Denmark. He conducted the majority of his PhD studies at UC Berkeley and was a Novartis Fellow of the Life Sciences Research Foundation at UC Berkeley, where he studied mammalian brain development. In 2000, Dr Hansen joined Sunesis Pharmaceuticals, where he was instrumental in applying Sunesis technology to the drug discovery process. During his 8 years at Sunesis, Dr Hansen advanced to Associate Director of Biology and led programs in metabolic disease, auto-immunity, and oncology, participating in two programs that entered clinical development. In addition, Dr Hansen managed research partnerships with Johnson & Johnson and Biogen Idec, and through participation in numerous partnering discussions, he gained significant business development experience. Dr Hansen also led the committee for new target initiatives and served on the Research Operations Team overseeing all research from project initiation through Phase II. An author on more than 20 patent applications and scientific publications Dr Hansen oversees Carmot’s biology research.